Biomarkers of ADHD Treatment Response (BAT)
ADHD
About this trial
This is an interventional treatment trial for ADHD focused on measuring Electroencephalography, ADHD, Event related potentials, Stimulants
Eligibility Criteria
Inclusion Criteria: Pediatric patients ages 7-11 seen at the Children's Hospital Primary Care Center Have a diagnosis of ADHD or referred for an ADHD evaluation Have not previously trialed stimulant medication Exclusion Criteria: Diagnoses of intellectual disability, autism, prior suicide attempt, current psychotropic medication use, known genetic syndrome, color-blindness History of nonfebrile seizures Gestational age < 32 weeks Prenatal alcohol or substance exposure Medical conditions that contraindicate psychostimulant use (e.g., cardiac concerns).
Sites / Locations
- 2 Brookline PlaceRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Methylphenidate Trial
Mixed Amphetamine Salts Trial
3-week methylphenidate trial with weekly dose adjustments.
3-week trial of mixed amphetamine salts with weekly dose adjustments.